Dr Joaquin Mateo speaks to ecancer about molecular profiling in prostate cancer.

He discusses the key challenges for clinical implementation in prostate cancer.

He initially talks about the unmet needs in prostate cancer management. He expands on genomic DNA testing, transcriptome RNA profiling, protein expression (IHC), methylation assays and proteomic assays.

Dr Mateo also discusses the guidelines on genomic testing for prostate cancer. He expands on when to test, the types of testing and what may come in the future.